Topic Dossier

Generic Versions of Ozempic Coming to India, China, and Canada

First article: 19 mar. 2026, 06:00 | Last update: 19 mar. 2026, 06:00 | 1 source | 1 article

Multiple sources. Less manipulation.

Editorial Analysis

Based on 1 source, 1 article

The pharmaceutical landscape is set to change in India, China, and Canada with the introduction of generic versions of Ozempic, a popular drug used for treating diabetes and promoting weight loss. This development is anticipated to significantly reduce the cost of the medication, making it more accessible to a larger segment of the population in these countries. The increased availability of generic Ozempic could also impact the market share of the original brand-name drug.

Articles about this topic

Ozempic Is About to Go Generic in India, China and Canada Foto: New York Times
New York Times 19 mar. 2026, 06:00 (1 day ago)

Ozempic Is About to Go Generic in India, China and Canada

In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster weight loss drug, opening the door for cheaper competing versions.

Read on New York Times →